<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-PNG-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Papouasie-Nouvelle-Guin&#xE9;e (la): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Papua New Guinea: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Papua New Guinea</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2023-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="PG" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="PG" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Port Moresby</narrative>
   </name>
   <administrative code="PG" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-9.44314 147.17972</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">2586613</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">4174840</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">3903672</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">568113</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">290276</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="PNGPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">880720</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-CHAI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">14913</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">1049023</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">641957</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-ABT ASSOC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">339838</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ABT ASSOC (Abt Associates Inc)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Abt Associates Inc</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-CDC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">750000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">258635</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">15000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1545560</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1265807</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-ABT ASSOC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1094459</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ABT ASSOC (Abt Associates Inc)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Abt Associates Inc</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-CDC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">250000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">218707</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">55251</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1029502</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">1255752</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-ABT ASSOC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-ABT ASSOC (Abt Associates Inc)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Abt Associates Inc</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">234059</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">334054</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="PNGPEF-TCA-ABT ASSOC2023">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">290276</value>
   <description>
    <narrative xml:lang="EN">2023 Operational budget for PEF-TCA-ABT ASSOC (Abt Associates Inc)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Abt Associates Inc</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000947">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">660540</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000748">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-03"></transaction-date>
   <value currency="USD" value-date="2019-12-03">220180</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001736">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">750000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001205">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">250000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001338">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">6513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003845">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">3973</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000200">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-10-29"></transaction-date>
   <value currency="USD" value-date="2019-10-29">3287</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003729">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-09"></transaction-date>
   <value currency="USD" value-date="2020-09-09">14973</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003776">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-16"></transaction-date>
   <value currency="USD" value-date="2020-09-16">24955</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001953">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">19964</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001954">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">19964</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006421">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">120825</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006420">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">19964</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-12626</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000009">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">12626</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">126</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000948">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">953657</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">95366</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">189142</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">981980</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-95366</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">95366</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">279072</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">163663</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004024">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-26"></transaction-date>
   <value currency="USD" value-date="2021-08-26">702175</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">601835</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">40122</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">760770</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-40122</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">40122</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">464915</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004708">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">1002162</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-png-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan PNG 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-png-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan PNG 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-png-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan PNG 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-png-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan PNG 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-png-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan PNG 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-png-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan PNG 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-papua-new-guinea-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Papua New Guinea 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-papua-new-guinea-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Papua New Guinea 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-PNG" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">v) HSS2 supported CCE deployment and rehabilitation completed and evaluation report submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NDOH Health Facility Standard Branch, National Immunisation Programme, provincial health authorities and immunisation stakeholders on strengthening immunisation Supply Chain and Logistics Management (iSCM):
i) Technical assistance to implement the CCEOP-ODP and HSS2-iSCM activities including distribution, installation &amp; commissioning of CCEs at health facilities in provinces, monitoring the functionality of the equipment guided by the CCEOP Project Managemet Team (PMT), capacity building and mentoring of the biomedical technicians on CCE maintenance in the provinces;
ii) Effective functioning of National Logistics Working Group (NLWG) to guide and monitor the implementation of the immunisation supply chain logistics management (iSCLM) and strengtheing the iSCLM systems;
iii) Technical assistance to ensure Effective Vaccine Management (EVM) at all levels of supply chain and develop semi-annual Cold Chain Equipment (CCE) inventory;
iv) Tehcnical assistance to procurement services of vaccines, cold chain and other immunisation supplies.
v) Monitoring iSCM data management guided by the newly developped SOPs to improve vaccine distribution, temperature monitoirng with low and high alarm, stock management, and wastage.">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">20 Ice Lined Refrigerators, 78 Icepack freezers, 224 Solar Direct Drive (SDD) including assorted spare parts and accessories, Voltage Stabilizers, Temperature monitoring devices procured and distributed to 22 provinces through technical &amp; logistic supports. As of October 90 CCEs installed and commissioned and the remaining ongoing. Process slowed down due to COVID-19 cases surge, movement restrictions of technicians etc.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i) CCE inventory tool updated and semiannual CCE inventory available.
ii) CCEOP supported equipment rollout completed, evaluation report submitted.
iii) HSS2 supported CCE deployment plan finalized for completing the CCE rehabilitation
iv) iSCM temperature monitoring study started.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NDOH Health Facility Standard Branch, National Immunisation Programme, provincial health authorities and immunisation stakeholders on strengthening immunisation Supply Chain and Logistics Management (iSCM):
i) Technical assistance to implement the CCEOP-ODP and HSS2-iSCM activities including distribution, installation &amp; commissioning of CCEs at health facilities in provinces, monitoring the functionality of the equipment guided by the CCEOP Project Managemet Team (PMT), capacity building and mentoring of the biomedical technicians on CCE maintenance in the provinces;
ii) Effective functioning of National Logistics Working Group (NLWG) to guide and monitor the implementation of the immunisation supply chain logistics management (iSCLM) and strengtheing the iSCLM systems;
iii) Technical assistance to ensure Effective Vaccine Management (EVM) at all levels of supply chain and develop semi-annual Cold Chain Equipment (CCE) inventory;
iv) Tehcnical assistance to procurement services of vaccines, cold chain and other immunisation supplies.
v) Monitoring iSCM data management guided by the newly developped SOPs to improve vaccine distribution, temperature monitoirng with low and high alarm, stock management, and wastage.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">i) 2021 CCE inventory has been updated regularly to monitor the impact of ongoing rehabilitation and to monitor the iSCM performances. The recent inventory updated in June 2021, analyzed and report presented in the NLWG. ii) 98% CCEOP equipment rollout completed, awaiting evaluation on the 30th of June 2021. iii) HSS2 supported CCE rollout ongoing, where, 224 SDD distributed nationwide as per final ODP in June 2021, awaiting installation. iv) Temp monitoring study delayed due the COVID-19 Vaccine roll out activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Meeting conducted.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Second digital health workshop building on recommendations from first workshop - to be defined further once final report and recommendations completed.">
      <location ref="PG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Digital Helath Workshop could not be conducted due to COVID-19 restrictions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A flip chart developed for immunization awareness building in communities, to be used by the health facility staffs during community outreach sessions and at health facility sessions.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to Health Promotion Unit in NDOH and Health Promotion officers in PHA to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for immunisation programme:
i) Support Health promotion branch to develop and filed test communicaiton message for immunization demand generation;
ii) Technical support to national health promotion branch to develop technical capacity of provincial health promotion officers;
ii) Support national and provincial health promotion office to develop IEC materials for immunziaiton programme;
iii) Support provinces to strenthen immunizaiton advocacy and demend gerenation skill among the district and health facility staffs.">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Finalization and printing of flipchart artwork has been delayed due to COVID-19 response and vaccine rollout priorities . It is planned to completed and distributed by Oct 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to Health Promotion Unit in NDOH and Health Promotion officers in PHA to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for immunisation programme:
i) Support Health promotion branch to develop and filed test communicaiton message for immunization demand generation;
ii) Technical support to national health promotion branch to develop technical capacity of provincial health promotion officers;
ii) Support national and provincial health promotion office to develop IEC materials for immunziaiton programme;
iii) Support provinces to strenthen immunizaiton advocacy and demend gerenation skill among the district and health facility staffs.">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Finalization and printing of flipchart artwork has been delayed due to COVID-19 response and vaccine rollout priorities . It is planned to completed and distributed by Oct 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to Health Promotion Unit in NDOH and Health Promotion officers in PHA to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for immunisation programme: i) Support Health promotion branch to develop and filed test communicaiton message for immunization demand generation; ii) Technical support to national health promotion branch to develop technical capacity of provincial health promotion officers; ii) Support national and provincial health promotion office to develop IEC materials for immunziaiton programme; iii) Support provinces to strenthen immunizaiton advocacy and demend gerenation skill among the district and health facility staffs.">
      <location ref="PG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">To be reprogrammed/deferred to 2022 TCA milestone and UNICEF Annual Work Plan due to the repurposing of TA for ongoing COVID19 vaccine rollout activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">IEC materials developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to Health Promotion Unit in NDOH and Health Promotion officers in PHA to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for routine immunisation programme:
i) Support Health promotion branch to develop and filed test communicaiton message for immunization demand generation activities;
ii) Technical support to national health promotion branch to develop technical capacity of provincial health promotion officers;
ii) Support national and provincial health promotion offices to develop and rollout IEC materials for immunziaiton programme;
iii) Support provinces to strenthen immunizaiton advocacy and demend gerenation skill among the CSOs, district and health facility staffs.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">IEC material has been developed for provinces, and in usage. More Printing in progress.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NGO/CSO mapping developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to Health Promotion Unit in NDOH and Health Promotion officers in PHA to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for routine immunisation programme:
i) Support Health promotion branch to develop and filed test communicaiton message for immunization demand generation activities;
ii) Technical support to national health promotion branch to develop technical capacity of provincial health promotion officers;
ii) Support national and provincial health promotion offices to develop and rollout IEC materials for immunziaiton programme;
iii) Support provinces to strenthen immunizaiton advocacy and demend gerenation skill among the CSOs, district and health facility staffs.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Mapping conducted in 2020 for CSO and Faith-based organizations. To be updated by August 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan to overcome vaccine demand-related barriers in high risk communities developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to NDOH &amp; PHA EPI Units and Health Promotion units to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for national immunisation programme:
i) Technical support to roll out the implementation of ACSM strategic plan and develop the customize PHA ACSM plan;
ii) Tehcnical support on ACSM institutional capacity building of health promotion units at national and provincial levels;
iii) Support to strenthen advocacy and demend gerenation activities for immunisation services through improved PHA engagement and investment.
iv) Support to identify barriers for immunizaiton demand and engage CSOs, NGO and VHV to improve immunizaiton demand.">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Partnership with CSO is being developed for the implementation of community engagement approach in four high risk provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ii) At least two Provinces will have Province-specific ACSM plans (based on the National Strategy) in place with specific interventions to build demand for RI services and clear plan to invest available resources and partners to strengthen these services through engagement of decision makers, leaders, and other partners (EHP &amp; Gulf). 
iii) CSO partners started immunization community awareness activities in 2 provinces (EHP &amp; Gulf).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to NDOH &amp; PHA EPI Units and Health Promotion units to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for national immunisation programme:
i) Technical support to roll out the implementation of ACSM strategic plan and develop the customize PHA ACSM plan;
ii) Tehcnical support on ACSM institutional capacity building of health promotion units at national and provincial levels;
iii) Support to strenthen advocacy and demend gerenation activities for immunisation services through improved PHA engagement and investment.
iv) Support to identify barriers for immunizaiton demand and engage CSOs, NGO and VHV to improve immunizaiton demand.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Provincial plan is available. Partnership Agreement signed with Save the Children for rollout and implement the ACSM plan and activities from Dec.2021. Partnership Agreement signed with Save the Children signed, fund had been proved and activities will start in Dec.2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A strategic and operational guideline on advocacy and leveraging of resources for immunisation developed based on the experience and evidence on implementing the national and provincial advocacy meetings and partnerships events.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Longer-term technical assistance to NDOH &amp; provincial Health Promotion Units and EPI Units to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for national immunisation programme: i) Technical support to develop and roll out the implementation of ACSM strategic plan; ii) Tehcnical support on ACSM institutional capacity building of health promotion units at national and provincial levels; iii) Support to strenthen advocacy and demend gerenation activities for immunisation services.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Operational guideline developed for rollout along with COVID19 advocacy and social mobilization activities at national and provincial levels.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Longer-term technical assistance to NDOH &amp; provincial Health Promotion Units and EPI Units to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for national immunisation programme:
i) Technical support to develop and roll out the implementation of ACSM strategic plan;
ii) Tehcnical support on ACSM institutional capacity building of health promotion units at national and provincial levels;
iii) Support to strenthen advocacy and demend gerenation activities for immunisation services.">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Rollout of provincial operational guidelines and conduct of the advocacy meetings have been delayed due to COVID-19 pandemic response and vaccine rollout priorities. It is planned to be completed by Oct 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Longer-term technical assistance to NDOH &amp; provincial Health Promotion Units and EPI Units to coordinate the planning, designing and monitoring the implementation of Advocacy, Communication and Social Mobilisation (ACSM) interventions for national immunisation programme:
i) Technical support to develop and roll out the implementation of ACSM strategic plan;
ii) Tehcnical support on ACSM institutional capacity building of health promotion units at national and provincial levels;
iii) Support to strenthen advocacy and demend gerenation activities for immunisation services.">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Rollout of provincial operational guidelines and conduct of the advocacy meetings have been delayed due to COVID-19 pandemic response and vaccine rollout priorities. It is planned to be completed by Oct 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan developed to reach out most poorly covered geographical areas based on 2020 coverage analysis.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to implement equity-focused immunisation programmes: 
i) Update immunisation coverage and equity status 2020 using NHIS data on coverage, cold chain inventory, HR status, and outreach activities to identify most deprived rural districts and urban areas.
ii) Assist provinces to deveop and implement equity improvement plan to improve coverage in most underserved communities in 4 provinces. 
iii) Assist PHA to develop EPI microplan focusing the hard to reach communities are captured.
iv) Assist PHA in technical skill building of the district and health facility managers and health workers on immunization service delivery in association with WHO and other immunization support providers.
v) Intensify supportive supervision, monitoring and mentoring of mid level and service delivery level immunizaiton managers.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Immunization coverage and health &amp; immunization system data analyzed in 2021 taking into consideration of the 2020 immunization performance. Plan and strategy developed to improve equity focused immunization programming and catch up activities in Western &amp; Madang provinces in addition to continuing efforts in Jiwaka and Central provinces in 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to implement equity-focused immunisation programmes: 
i) Update immunisation coverage and equity status 2020 using NHIS data on coverage, cold chain inventory, HR status, and outreach activities to identify most deprived rural districts and urban areas.
ii) Assist provinces to deveop and implement equity improvement plan to improve coverage in most underserved communities in 4 provinces. 
iii) Assist PHA to develop EPI microplan focusing the hard to reach communities are captured.
iv) Assist PHA in technical skill building of the district and health facility managers and health workers on immunization service delivery in association with WHO and other immunization support providers.
v) Intensify supportive supervision, monitoring and mentoring of mid level and service delivery level immunizaiton managers.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Immunization coverage and health &amp; immunization system data analyzed in 2021 taking into consideration of the 2020 immunization performance. Plan and strategy developed to improve equity focused immunization programming and catch up activities in Western &amp; Madang provinces in addition to continuing efforts in Jiwaka and Central provinces in 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Detailed PNG Immunisation Road-Map 2021-2025 developed, finalised and endorsed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Longer-term technical assistance to NDOH and PHAs to improve overall coordination and management of national immunisation programme: 
i) Strategic planning, programme design and development;
ii) Technical support to national EPI team to improve programme coordination mechanism e.g. ICC, NLWG, CCEOP PMT 
iii) Vaccine forecasting, procurement and mamangement;
iv) Cold chain systems strengthening;
v) Equity-focused immunization planning and implementation for the marginalised and underserved population;
vi) Technical capacity building for NDOH and PHA in intensifying supportive supervision and monitoring of immunization services at sub-national levels.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">The NIS contains the detailed roadmap to iSCM and immunization demand generation plan with strategies, cost calculation, monitoring plan etc for the period of 2021-25. During the NIS 2021-25 development process in 2021, in collaboration with other partners (WHO &amp; CHAI), it was ensured to analyze the current &amp; previous situation on immunization performance indicators and mapping has been incorporated for immunization financing, system strengthening, sustainability and ownership by the programme with particular focus on cold chain system strengthening, vaccine availability and system strengthening for vaccine uptake in the communities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Longer-term technical assistance to NDOH and PHAs to improve overall coordination and management of national immunisation programme: 
i) Strategic planning, programme design and development;
ii) Technical support to national EPI team to improve programme coordination mechanism e.g. ICC, NLWG, CCEOP PMT 
iii) Vaccine forecasting, procurement and mamangement;
iv) Cold chain systems strengthening;
v) Equity-focused immunization planning and implementation for the marginalised and underserved population;
vi) Technical capacity building for NDOH and PHA in intensifying supportive supervision and monitoring of immunization services at sub-national levels.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">The NIS contains the detailed roadmap to iSCM and immunization demand generation plan with strategies, cost calculation, monitoring plan etc for the period of 2021-25. During the NIS 2021-25 development process in 2021, in collaboration with other partners (WHO &amp; CHAI), it was ensured to analyze the current &amp; previous situation on immunization performance indicators and mapping has been incorporated for immunization financing, system strengthening, sustainability and ownership by the programme with particular focus on cold chain system strengthening, vaccine availability and system strengthening for vaccine uptake in the communities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Second year program evaluation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="8 STOP consultants, funded by Gavi, to provide in-country continuous support, technical assistance, capacity building or activities in support of national EPI programs. CDC funds will support 3 or 4 additional STOP consultants.">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Minor Delays In progress. Due to Covid-19, the program evaluation has not be completed. However the eight STOP consultants in PNG supported activities such as surveillance, data collection and analysis, monitoring, logistics (cold chain), capacity-building, social mobilization and advocacy, microplanning, and stakeholder/partner engagement for routine immunization, immunization campaigns, outbreak response, and vaccine introduction in the following provinces: East Sepik, Sandaun (West Sepik), Madang, Southern Highlands, Morobe, Central, Eastern Highlands, Jiwaka, and Chimbu (Simbu). They have conducted 1,057 total health facility visits, trained 593 total staff informally ?on-the-job? via supportive supervision, and 1,182 staff in formal group sessions. On average, STOP consultants spent over one-third (35%) of their time conducting coronavirus-related activities, one-quarter (25%) on polio, and the remaining 40% on other VPDs such as measles, tetanus, and rubella</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="8 STOP consultants, funded by Gavi, to provide in-country continuous support, technical assistance, capacity building or activities in support of national EPI programs. CDC funds will support 3 or 4 additional STOP consultants.">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Minor Delays on conducting program evaluation. STOP membes stayed in country for most of 2020, had a break in January and returned to country. Evaluation planned for q 4 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="8 STOP consultants, funded by Gavi, to provide in-country continuous support, technical assistance, capacity building or activities in support of national EPI programs. CDC funds will support 3 or 4 additional STOP consultants.">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Minor Delays on conducting program evaluation. STOP membes stayed in country for most of 2020, had a break in January and returned to country. Evaluation planned for q 4 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Field work conducted as planned</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Logistics support to STOP team members for travel and supportive supervision">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">STOP team conducted field supervision and mentoring of district supervisors in their assigned provinces on an average of 2 days per week. This resulted in higher quality implementation of COVID19 vaccine roll out, RI and VPD surveillance.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Logistics support to STOP team members for travel and supportive supervision">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">STOP team conducted field supervision and mentoring of district supervisors in their assigned provinces on an average of 2 days per week. This resulted in higher quality implementation of COVID19 vaccine roll out, RI and VPD surveillance.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Provide technical support to the National EPI team of NDoH to plan and prepare for subnational EPI review meetings/workshops</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Support the National and Provincial Health Team in all aspects of EPI planning, implementation and monitoring 
? Coordinate with NDoH to organize and conduct supportive supervisory visits to provinces and districts to improve the performance of EPI programme
? Collaborate with partners UNICEF, Immunization Support Providers (ISPs) and PPF (DFAT, GAVI and MFAT) to support the implementation of the Accelerated Routine EPI Strengthening Programme in 8 PPF supported provinces
? Organize trainings on immunization and VPD surveillance at national and sub-national level 
? Support the EPI program at the national and subnational level to ensure data analysis and management 
? Support provincial health team to strengthen Vaccine Preventable Disease Surveillance system at the sub national level 
? Collaborate with CDC to support STOP programme implementation and work directly with STOP team members as first level supervisor, including STOP ISDS team.">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Techncal support is given to the National EPI team on daily basis. There is regular monthly analysis of the RI data and information is used to plan corrective action.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Support the National and Provincial Health Team in all aspects of EPI planning, implementation and monitoring 
? Coordinate with NDoH to organize and conduct supportive supervisory visits to provinces and districts to improve the performance of EPI programme
? Collaborate with partners UNICEF, Immunization Support Providers (ISPs) and PPF (DFAT, GAVI and MFAT) to support the implementation of the Accelerated Routine EPI Strengthening Programme in 8 PPF supported provinces
? Organize trainings on immunization and VPD surveillance at national and sub-national level 
? Support the EPI program at the national and subnational level to ensure data analysis and management 
? Support provincial health team to strengthen Vaccine Preventable Disease Surveillance system at the sub national level 
? Collaborate with CDC to support STOP programme implementation and work directly with STOP team members as first level supervisor, including STOP ISDS team.">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Techncal support is given to the National EPI team on daily basis. There is regular monthly analysis of the RI data and information is used to plan corrective action.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support PHA to implement accelerated RI and VPD surveillance and improve data quality">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Subnational consultants have provided technical assistance to the PHA to improve the timeliness, completeness and overall quality of both RI data and VPD surveillance data. The subnational consultants mentor both health information officers and surveillance officers to guide them on improving data quality that is reported into the NHIS and used for case based surveillance.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and approaches developed to improve and sustain quality and safety of immunisation services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Work with the Government to develop and operationalize the National Immunization Strategy that will provide a framework for the workplans of next 5 years. 
? Provide technical advice to the government and international partners on the planning and implementation of the deployment of COVID-19 vaccine 
? Review and assist in the development of national and subnational level guidelines for AEFI surveillance and VPD surveillance
? Engage in strategic level dialogue to influence national strategy on AEFI, MR risk assessment, MR campaign, IPV 2nd dose introduction
? Support the National Department of Health to improve the capacity of the national and subnational immunization teams in immunization program planning, implementation and monitoring 
? Work with government, partners, and WHO regional staff in coordinating technical and financial assistance to the national immunization program. 
? Supervise the CDC STOP team">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Refresher training has been delivered on the topic of Injection Safety to all provincial EPI focal persons and this training has been cascaded down as part of the COVID-19 vaccine roll out training</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Service delivery related barriers of missed communities to access immunisation services identified and prioritized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the National and Provincial Health Team in all aspects of EPI planning, implementation and monitoring
? Support the Public Health Team at the Sub National Level to form Provincial EPI Program Management Committee
? Organize Mid-year Review of EPI programme for sub national EPI staff on intensification of EPI activities
? Support for the implementation of the Catch up RI activities in low performing provinces and districts, MR campiagn and IPV second dose introduction
? Support the EPI program at the national and sub national level to ensure data analysis and management
? Support provincial health team to strengthen Vaccine Preventable Disease Surveillance system at the sub national level
? Support the development of NDVP for COVID vaccine rollout and support vaccination rollout
? Conduct field supervisory support to CDC STOP team">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Subnational support has been provided to individual Provincial Operations Centers to increase capacity for monitoring and supervision of both RI and the COVID-19 vaccine introduction. In addition, on the job training is conducted at district and HF level for enhancing capacity for VPD surveillance. Two rounds of the RI catch up activity in lower performing provinces were planned and are currently underway. Regular meetings were conducted with the pertinent provincial officers to plan and monitor the activity.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="&quot;Work with the Government to develop and operationalize the National Immunization Strategy that will provide a framework for the workplans of next 5 years. 
? Provide technical advice to the government and international partners on the planning and implementation of the deployment of COVID-19 vaccine 
? Review and assist in the development of national and subnational level guidelines for AEFI surveillance and VPD surveillance
? Engage in strategic level dialogue to influence national strategy on AEFI, MR risk assessment, MR campaign, IPV 2nd dose introduction
? Support the National Department of Health to improve the capacity of the national and subnational immunization teams in immunization program planning, implementation and monitoring 
? Work with government, partners, and WHO regional staff in coordinating technical and financial assistance to the national immunization program. 
? Supervise the CDC STOP team">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">The National Immunization Strategy has been finalized and adopted by the Senior Executive Management Committee. This will serve as a framework of immunization workplan over the next 5 years and may guide the development of the Gavi Full Portfolio Planning. The National Deployment and Vaccination Plan was revised in August 2021 to reflect the second phase of the COVID-19 vaccine roll out and the VDI team continue to assist government to deploy COVID-19 vaccine in PNG. Guidelines for AEFI surveillance have been developed with focus on COVID-19 vaccines but also applicable for the RI. A VPD surveillance guideline specific for PNG has been written. A national MR SIA is planned for implementation in the 4th quarter of 2022 and planning for the Gavi MR grant application has started and currently in the initial stage of development. The WHO VDI team conducted provincial visits to support provinces for capacity building in RI in East Sepik, Enga, and Gulf provinces. The WHO VDI team supported the government to develop grant proposals for funds to implement the COVID-19 vaccine deployment and the IPV2 introduction. The introduction of 2nd dose IPV has progressed, and currently national and provincial level health officers have received training on technical aspects of introducing the vaccine. Data recording tools have been developed and will be printed and distributed to all provinces. Provinces have begun administering the 2nd dose of IPV in the past few months. Supportive supervision and mentoring have been provided to six STOP team consultants.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support the development of NDVP for the rollout of COVID vaccine</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the National and Provincial Health Team in all aspects of EPI planning, implementation and monitoring
? Support the Public Health Team at the Sub National Level to form Provincial EPI Program Management Committee
? Organize Mid-year Review of EPI programme for sub national EPI staff on intensification of EPI activities
? Support for the implementation of the Catch up RI activities in low performing provinces and districts, MR campiagn and IPV second dose introduction
? Support the EPI program at the national and sub national level to ensure data analysis and management
? Support provincial health team to strengthen Vaccine Preventable Disease Surveillance system at the sub national level
? Support the development of NDVP for COVID vaccine rollout and support vaccination rollout
? Conduct field supervisory support to CDC STOP team">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">THe NDVP was developed submitted and passed review by set timeline</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Scoping exericse on digital technology options</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Digital solutions for COVID-19 vaccine oversight to track vaccines into arms and dashboard for monitoring">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Consultations for a rapid assessment completed. A report and presentation on findings are being finalized. The team is hoping to organize a presentation on results with other development partners soon as possible as they hope to use them to inform investments.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Digital microplans developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Digital solutions for COVID-19 vaccine oversight to track vaccines into arms and dashboard for monitoring">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">TA on digital options for tracking and monitoring vaccines in PNG was completed. Discussions with Government and partners on options for implementing a digital solution, piloting and developing of digital microplans are pending.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An EVM assessment is conducted and the comprehensive Improvement Plan (cIP) developed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NDOH Health Facility Standard Branch, National Immunisation Programme, provincial health authorities and immunisation stakeholders on strengthening immunisation Supply Chain and Logistics Management (iSCM):
i) Technical assistance to implement the CCEOP-ODP and PSR-iSCM activities including distribution, installation &amp; commissioning of CCEs at health facilities in provinces, monitoring the functionality of the equipment guided by the CCEOP Project Managemet Team (PMT), capacity building and mentoring of the biomedical technicians on CCE maintenance in the provinces;
ii) Effective functioning of National Logistics Working Group (NLWG) to guide and monitor the implementation of the immunisation supply chain logistics management (iSCLM) and strengtheing the iSCLM systems;
iii) Technical assistance to ensure Effective Vaccine Management (EVM) at all levels of supply chain and develop semi-annual Cold Chain Equipment (CCE) inventory;
iv) Tehcnical assistance to procurement services of vaccines, cold chain and other immunisation supplies.
v) Monitoring iSCM data management guided by the newly developped SOPs to improve vaccine distribution, temperature monitoirng with low and high alarm, stock management, and wastage.
vi) Contribute to the overall supply chain reform agenda of the health sector guided by the the iSCM HR/Data assessment recommendations.">
      <location ref="PG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">The EVM assessment has been pushed to 2021-22, due to the delayed implementation of CCEOP and HSS2 supported CCE rehabilitation, as well as due to COVID19 pandemic. The EVM assessment operation plan is now being developed, with a view to conduct it in Q4 2021 and Q1 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NDOH Health Facility Standard Branch, National Immunisation Programme, provincial health authorities and immunisation stakeholders on strengthening immunisation Supply Chain and Logistics Management (iSCM):
i) Technical assistance to implement the CCEOP-ODP and PSR-iSCM activities including distribution, installation &amp; commissioning of CCEs at health facilities in provinces, monitoring the functionality of the equipment guided by the CCEOP Project Managemet Team (PMT), capacity building and mentoring of the biomedical technicians on CCE maintenance in the provinces;
ii) Effective functioning of National Logistics Working Group (NLWG) to guide and monitor the implementation of the immunisation supply chain logistics management (iSCLM) and strengtheing the iSCLM systems;
iii) Technical assistance to ensure Effective Vaccine Management (EVM) at all levels of supply chain and develop semi-annual Cold Chain Equipment (CCE) inventory;
iv) Tehcnical assistance to procurement services of vaccines, cold chain and other immunisation supplies.
v) Monitoring iSCM data management guided by the newly developped SOPs to improve vaccine distribution, temperature monitoirng with low and high alarm, stock management, and wastage.
vi) Contribute to the overall supply chain reform agenda of the health sector guided by the the iSCM HR/Data assessment recommendations.">
      <location ref="PG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">The EVM assessment has been pushed to 2021-22, due to the delayed implementation of CCEOP and HSS2 supported CCE rehabilitation, as well as due to COVID19 pandemic. The EVM assessment operation plan is now being developed, with a view to conduct it in Q4 2021 and Q1 2022.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NDOH Health Facility Standard Branch, National Immunisation Programme, provincial health authorities and immunisation stakeholders on strengthening immunisation Supply Chain and Logistics Management (iSCM): i) Technical assistance to implement the CCEOP-ODP and PSR-iSCM activities including distribution, installation &amp; commissioning of CCEs at health facilities in provinces, monitoring the functionality of the equipment guided by the CCEOP Project Managemet Team (PMT), capacity building and mentoring of the biomedical technicians on CCE maintenance in the provinces; ii) Effective functioning of National Logistics Working Group (NLWG) to guide and monitor the implementation of the immunisation supply chain logistics management (iSCLM) and strengtheing the iSCLM systems; iii) Technical assistance to ensure Effective Vaccine Management (EVM) at all levels of supply chain and develop semi-annual Cold Chain Equipment (CCE) inventory; iv) Tehcnical assistance to procurement services of vaccines, cold chain and other immunisation supplies. v) Monitoring iSCM data management guided by the newly developped SOPs to improve vaccine distribution, temperature monitoirng with low and high alarm, stock management, and wastage. vi) Contribute to the overall supply chain reform agenda of the health sector guided by the the iSCM HR/Data assessment recommendations.">
      <location ref="PG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">To be reprogrammed/deferred to 2022 TCA milestone and UNICEF Annual Work Plan due to the repurposing of TA for ongoing COVID19 vaccine rollout activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Provide leadershop and&#xA0;guidance to STOP team members to ensure their optimal output towards building capacity of subnational teams</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Work with the Government in the development of national policies, strategies, and plans to improve access to and coverage of immunization services, increase programme impact and strengthen the quality of services, injection safety and vaccines
? Provide technical advice to the government and international partners on the design, implementation, and evaluation of immunization program
? Support the Government to develop and evaluate strategies for improving vaccination coverage and quality of services
? Review and assist in the development of national and subnational level guidelines
? Engages in strategic level dialogue to influence national policy and strategy on AEFI, NITAG, MR risk assessment, MR campaign, new vaccines introduction
? Support the National Department of Health to improve the capacity of the national immunization team in all aspects of immunization programme planning, implementation and monitoring 
? Leads the WHO EPI country team to develop and execute WHO work plans and ensures that monitoring mechanisms to be set up to track and evaluate the success.
? Work with government, partners, and WHO regional and head quarter staff in coordinating technical and financial assistance to the national immunization program. Coordination, collaboration, partnership, and advocacy with the Government, partners and other WHO staff to ensure sustainable financing for immunization programme to address coverage and impact of the programme.
? Coordinate partners (GAVI, US-CDC, World Bank, ADB, DFAT, UNICEF, OSF) inputs to ensure optimal and efficient use of financial and human resources through Interagency Coordination Committee (ICC) as well as convene other ad hoc meetings as needed. 
? Supervise the CDC STOP team">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">STOP team members have completed the half year mark 2021 and have made signficant contributions to COVID-19 vaccine rollout, RI system strengthening and VPD surveillance system strengthening</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Work with the Government in the development of national policies, strategies, and plans to improve access to and coverage of immunization services, increase programme impact and strengthen the quality of services, injection safety and vaccines
? Provide technical advice to the government and international partners on the design, implementation, and evaluation of immunization program
? Support the Government to develop and evaluate strategies for improving vaccination coverage and quality of services
? Review and assist in the development of national and subnational level guidelines
? Engages in strategic level dialogue to influence national policy and strategy on AEFI, NITAG, MR risk assessment, MR campaign, new vaccines introduction
? Support the National Department of Health to improve the capacity of the national immunization team in all aspects of immunization programme planning, implementation and monitoring 
? Leads the WHO EPI country team to develop and execute WHO work plans and ensures that monitoring mechanisms to be set up to track and evaluate the success.
? Work with government, partners, and WHO regional and head quarter staff in coordinating technical and financial assistance to the national immunization program. Coordination, collaboration, partnership, and advocacy with the Government, partners and other WHO staff to ensure sustainable financing for immunization programme to address coverage and impact of the programme.
? Coordinate partners (GAVI, US-CDC, World Bank, ADB, DFAT, UNICEF, OSF) inputs to ensure optimal and efficient use of financial and human resources through Interagency Coordination Committee (ICC) as well as convene other ad hoc meetings as needed. 
? Supervise the CDC STOP team">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">STOP team members have completed the half year mark 2021 and have made signficant contributions to COVID-19 vaccine rollout, RI system strengthening and VPD surveillance system strengthening</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Develop PNG cMYP 2021-2025 draft document by Q4 and ensure alignment with National Health Plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Work with the Government in the development of national policies, strategies, and plans to improve access to and coverage of immunization services, increase programme impact and strengthen the quality of services, injection safety and vaccines ? Provide technical advice to the government and international partners on the design, implementation, and evaluation of immunization program ? Support the Government to develop and evaluate strategies for improving vaccination coverage and quality of services ? Review and assist in the development of national and subnational level guidelines ? Engages in strategic level dialogue to influence national policy and strategy on AEFI, NITAG, MR risk assessment, MR campaign, new vaccines introduction ? Support the National Department of Health to improve the capacity of the national immunization team in all aspects of immunization programme planning, implementation and monitoring ? Leads the WHO EPI country team to develop and execute WHO work plans and ensures that monitoring mechanisms to be set up to track and evaluate the success. ? Work with government, partners, and WHO regional and head quarter staff in coordinating technical and financial assistance to the national immunization program. Coordination, collaboration, partnership, and advocacy with the Government, partners and other WHO staff to ensure sustainable financing for immunization programme to address coverage and impact of the programme. ? Coordinate partners (GAVI, US-CDC, World Bank, ADB, DFAT, UNICEF, OSF) inputs to ensure optimal and efficient use of financial and human resources through Interagency Coordination Committee (ICC) as well as convene other ad hoc meetings as needed. ? Supervise the CDC STOP team">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">The final draft of the National Immunzation Strategy has been prepared and is awaiting reveiw by Senior Executive Committee</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training of staff on AEFI surveillance and establishing provincial AEFI response teams in 2 Gavi supported Provinces to stregnthen RI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishment and support of Adverse Events Following Immunization (AEFI) Surveillance and response team at the national and sub national level">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">AEFI surveillance training was conducted as part of the preparation for COVID-19 vaccine roll out. Provincial AEFI COmmittees ahve been establisted and Workshop on Causality completed for the National AEFI COmmittee.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rota Virus Surveillance (Goroka) and IB-VPD surveillance (PMGH) will be functional in the country</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support RV hospital-based surveillance in Goroka, Eastern Highlands Province and IB-VPD surveillance at the Port Moresby General Hospital in Port Moresby">
      <location ref="PG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Both IMR Goroka and PMGH have been overburdened with duties related to the COVID-19 response. Other lab surveillance activities have been given less attention.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">VPD surveillance established and training conducted in 6 provinces and corresponding districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NDOH to strengthen VPD surveillance network at the provincial and district level">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">On the job training ffor VPD surveillance continues at the subnational level. When possible this is integrated with the training for COVID-19 surveillance. Training workshops specific for VPD surveillance could not be conducted as planned due to COVID-19 response</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NITAG feasibility assessment will be done</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Establishment of NITAG and it&apos;s strengthening activities">
      <location ref="PG"></location>
     </target>
     <actual value="Major Delays">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">This activity has been delayed due to COVID-19 pandemic response</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Survey and implementation tools adapted to PNG context</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facebook survey on vaccine hesitancy, misinformation and shaping of COVID-19 vaccine messages">
      <location ref="PG"></location>
     </target>
     <actual value="On Track">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">?	The survey, implemented in collaboration with the Mind Behavior and Development Unit in the Poverty GP has been adapted to PNG context and translated. The FB survey targets a minimum of 5,000 respondents across demographic groups. It has been launched and over 1,000 responses received so far. The survey team anticipates running the survey for about 2 weeks or longer depending on how soon target respondent numbers are reached. The exercise aims to inform the next phase of work which will focus on fine tuning key messages. 
?	As a part of this exercise a brief collating various surveys collecting information on vaccine hesitancy in PNG has been written as well ? this work is supported in coordination with the high frequency phone survey.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">First round of survey completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facebook survey on vaccine hesitancy, misinformation and shaping of COVID-19 vaccine messages">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">This activity was completed. There is also additional work that might be done on a research experiment testing and developing a health worker toolkit/aide to manage patients with vaccine hesitancy.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i) Strategic planning documentation (EVM-IP, CIP, cold chain rehabilitation plan) supported and submitted to MoH.
ii) National Logistic Working Group funtioned with strategic and technical support to oversee the cold chain rehabilitation. immunizaiton supply chain
iii) NDOH completed forecast of vaccine for 2022</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to NDOH and PHAs to improve strategies, coordination and management of national immunisation programme: 
i) Strategic planning, programme design and development;
ii) Technical support to NDOH, Immunization partners, national EPI team to improve programme coordination mechanism e.g. ICC, NLWG, CCEOP PMT 
iii) Vaccine forecasting, procurement and mamangement;
iv) Cold chain systems strengthening;
v) Equity-focused immunization planning and implementation for the marginalised and underserved population;
vi) Technical capacity building for NDOH, national EPI team, and PHAs in intensifying supportive supervision and monitoring of immunization services at sub-national levels.
vii) Strategic and technical support to NDOH to plan for MR follow up campaign 2022 and guide NDOH to collaborate with Gavi and other immunizaiton partner to access resource, vaccines and related support. 
ix) Technical support and guidance to NDOH to access IPV and plan for rollout of New vaccine such as HPV, Rota">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">2022 EVM Assessment operation plan has been developed and submitted to NDOH, which is under costing now. Cold chain rehabilitation plan and ODPs already updated, submitted, approved and currently being implemented. NLWG is fully functional and overseeing the cold chain equipment rehabilitation and routine and COVID19 vaccine distribution throughout the country. One NLWG meeting held in October 2021. In collaboration between NDOH and UNICEF, the immunization forecast for 2022 has been developed, submitted to SD, currently at final stage.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Systems in place to track vaccine stocks at all levels and corrective measures undertaken</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to NDOH and PHAs to improve strategies, coordination and management of national immunisation programme: 
i) Strategic planning, programme design and development;
ii) Technical support to NDOH, Immunization partners, national EPI team to improve programme coordination mechanism e.g. ICC, NLWG, CCEOP PMT 
iii) Vaccine forecasting, procurement and mamangement;
iv) Cold chain systems strengthening;
v) Equity-focused immunization planning and implementation for the marginalised and underserved population;
vi) Technical capacity building for NDOH, national EPI team, and PHAs in intensifying supportive supervision and monitoring of immunization services at sub-national levels.
vii) Strategic and technical support to NDOH to plan for MR follow up campaign 2022 and guide NDOH to collaborate with Gavi and other immunizaiton partner to access resource, vaccines and related support. 
ix) Technical support and guidance to NDOH to access IPV and plan for rollout of New vaccine such as HPV, Rota">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Both dashboard (ViVa for national store) and physical stock tracking (for national &amp; sub-national levels) of vaccines are in place and functioning well. The dashboard is real-time and the physical stock count is conducted once in a month. The sub-national stock counts are still irregular and incomplete. Nonetheless, the physical stock counts are the basis of vaccine replenishment activities for different store levels.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">iii) At least 2 unreached/ underserved urban settlement reach 80% of never vaccinated children with a doses of Penta, PCV, OPV and MR vaccines in NCD province.

iv) At least 2 rural underserved settlement reach 80% of never vaccinated children with a doses of Penta, PCV, OPV and MR vaccines in Central and Jiwaka province.

v) EPI micro planning proccess supported in 4 provinces in association with PHA, WHO and PPF ISP partners (NCD, Central, Jiwaka and Simbu provinces)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to improve coverage and equity in immunisation programmes in selected provinces: 
i) Analyze immunization coverage and health system data to identify the most marginalized communities.
ii) Provide tehcnical assistance to provinces to deveop microplan for improving coverage and equity in most underserved communities in 4 provinces. 
iii) Assist PHA to develop EPI microplan focusing the hard to reach communities are captured.
v) Intensify supportive supervision, monitoring and mentoring of mid level and service delivery level immunizaiton managers.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">Two urban settlements in NCD conducted equity focused microplanning and conducted mobile session and reached 243 children in 2021. Two rural districts/communities WHP and Central provinces conducted equity focused microplanning and conducted mobile session and reached 1,761 children in 2021, of them, 1,393 were zero dose children. Technical support provided for development of equity focused routine immunization micro planning to NCD, Central, Jiwaka and Simbu provinces.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">i) Immunisation coverage and health system data analyzed for the entire country, marginalized provinces identified and operation plan developed to improve coverge and equity in 2 provinces. 

ii) Immunizaiton in practice training supported, facilitated and completed in two provinces in association with other partners.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to improve coverage and equity in immunisation programmes in selected provinces: 
i) Analyze immunization coverage and health system data to identify the most marginalized communities.
ii) Provide tehcnical assistance to provinces to deveop microplan for improving coverage and equity in most underserved communities in 4 provinces. 
iii) Assist PHA to develop EPI microplan focusing the hard to reach communities are captured.
v) Intensify supportive supervision, monitoring and mentoring of mid level and service delivery level immunizaiton managers.">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
      <comment>
       <narrative xml:lang="EN">i) Immunization coverage and health &amp; immunization system data analyzed in 2021 taking into consideration of the 2020 immunization performance. Plan and strategy developed to improve equity focused immunization programming and catch up activities in Western &amp; Madang provinces in addition to continuing efforts in Jiwaka and Central provinces in 2021. ii) Immunization in practice training was conducted and supported in Central province in 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete year one of field activities in selected provinces</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Introduction of STOP Immunization and Surveillance Data Specialist (ISDS)like intervention 5 STOP ISDS and 1 ISDS Coordinator deployed to priority provinces to improve immunization and VPD surveillance data management, quality and use, through sustained supportive supervision">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Introduction of STOP Immunization and Surveillance Data Specialist (ISDS)like intervention 5 STOP ISDS and 1 ISDS Coordinator deployed to priority provinces to improve immunization and VPD surveillance data management, quality and use, through sustained supportive supervision">
      <location ref="PG"></location>
     </target>
     <actual value="Completed">
      <location ref="PG"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on key DHIS2 skills</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support configuration and installation of DHIS2">
      <location ref="PG"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="PG"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support configuration and installation of DHIS2">
      <location ref="PG"></location>
     </target>
     <actual>
      <location ref="PG"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">DHIS2 installed and configured
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support configuration and installation of DHIS2">
      <location ref="PG"></location>
     </target>
     <actual>
      <location ref="PG"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
